Avelox, Moxifloxacin News

Objective To determine whether there is a benefit in clinical outcomes with the use of topical corticosteroids as adjunctive therapy in the treatment of bacterial corneal ulcers.

The TB Alliance announces the launch of a collaboration with the National Institute of Allergy and Infectious Diseases' AIDS Clinical Trial Group to conduct and help complete a Phase III clinical trial testing potentially faster-acting tuberculosis treatments.

Cardiac safety of a drug is normally assessed as early as possible, ideally before the start of a thorough QT/QTc study 1 which serves to confirm the absence of a signal.

Avelox is actually fourth-generation fabricated flouroquinolone healthful solution underneath the general label Moxifloxacin.

Upper and lower respiratory tract infections account for a substantial portion of outpatient antibiotic utilization.